RFW De Cock, C Piana, EHJ Krekels, M Danhof… - European journal of …, 2011 - Springer
Children differ from adults in their response to drugs. While this may be the result of changes in dose exposure (pharmacokinetics [PK]) and/or exposure response (pharmacodynamics …
Irrespective of whether a drug is in development or already available on the market, the current paradigm for paediatric dose selection does not guarantee safe and effective dosing …
Morphine is a widely used opioid for treatment of moderate to severe pain, but large interindividual variability in patient response and no clear guidance on how to optimise …
In this manuscript we review the state of cardiac cell modelling in the context of international initiatives such as the IUPS Physiome and Virtual Physiological Human Projects, which aim …
M Tod, V Jullien, G Pons - Clinical pharmacokinetics, 2008 - Springer
The pharmacokinetics and pharmacodynamics of drugs are different in adult and paediatric populations, the latter being particularly heterogeneous. These differences in …
These two items now work properly in nm751. 2) For problems using analytical 2nd derivatives (such as $ EST LAPLACE NOINTERACTION without NUMERICAL, or $ SIM …
Several developments have facilitated the practical application and increased the general use of optimal design for nonlinear mixed effects models. These developments include new …
E Germovsek, I Lutsar, K Kipper… - Journal of …, 2018 - academic.oup.com
Background Sepsis and bacterial meningitis are major causes of mortality and morbidity in neonates and infants. Meropenem, a broad-spectrum antibiotic, is not licensed for use in …
Population pharmacokinetic (PK)–pharmacodynamic (PKPD) models are increasingly used in drug development and in academic research; hence, designing efficient studies is an …